These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29938321)

  • 1. Prevention of Cardiotoxicities With Traditional and Novel Chemotherapeutic Agents.
    Sharalaya Z; Collier P
    Curr Heart Fail Rep; 2018 Aug; 15(4):260-269. PubMed ID: 29938321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced cardiotoxicity in children.
    Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
    Pai VB; Nahata MC
    Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
    Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
    Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
    Guha A; Armanious M; Fradley MG
    Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.
    Avila MS; Siqueira SRR; Ferreira SMA; Bocchi EA
    Methodist Debakey Cardiovasc J; 2019; 15(4):267-273. PubMed ID: 31988687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Chemotherapy Induced Cardiomyopathy.
    Payne DL; Nohria A
    Curr Heart Fail Rep; 2017 Oct; 14(5):398-403. PubMed ID: 28779279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule Inhibitors and Cardiotoxicity.
    Joshi AM; Prousi GS; Bianco C; Malla M; Guha A; Shah M; Brown SA; Patel B
    Curr Oncol Rep; 2021 Feb; 23(3):30. PubMed ID: 33582937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions : Where Do we Stand with Chemotherapyinduced Cardiotoxicity?
    Robinson EL; Azodi M; Heymans S; Heggermont W
    Curr Heart Fail Rep; 2020 Dec; 17(6):357-364. PubMed ID: 32964378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular toxicity of biologic agents for cancer therapy.
    Bhave M; Akhter N; Rosen ST
    Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced cardiomyopathy.
    Higgins AY; O'Halloran TD; Chang JD
    Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
    Nelson-Veniard M; Thambo JB
    Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
    Vejpongsa P; Yeh ET
    J Am Coll Cardiol; 2014 Sep; 64(9):938-45. PubMed ID: 25169180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer.
    Thuny F; Huttin O; Ederhy S
    Arch Cardiovasc Dis; 2019 Oct; 112(10):550-558. PubMed ID: 31522992
    [No Abstract]   [Full Text] [Related]  

  • 17. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity relatively common in cancer treatment].
    Bühlmann Lerjen E; Hübbert L; Papakonstantinou A; Hedayati E; Linde C; Månsson Broberg A
    Lakartidningen; 2016 Jun; 113():. PubMed ID: 27299327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors.
    Sadurska E
    Pediatr Cardiol; 2015 Aug; 36(6):1112-9. PubMed ID: 25939787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.